Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04893226 · ClinicalTrials.gov registry record · NA

Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women

A NA study of Metabolic Syndrome and Postmenopausal Symptoms, sponsored by Julie Pendergast.

Recruiting
Registry status
NA
Development phase
164
Enrollment target
1
Study location

NCT04893226 is a NA study of Metabolic Syndrome and Postmenopausal Symptoms that is actively recruiting participants, run by Julie Pendergast. The registered enrollment target is 164 participants, below the 1,203-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04893226, a NA study of Metabolic Syndrome and Postmenopausal Symptoms, is actively recruiting participants, sponsored by Julie Pendergast.

RECRUITING
Registry status
NA
Development phase
164 participants
Enrollment target
1
Study location

Study Summary

This is a randomized, parallel two-arm clinical trial design to study the efficacy of time-restricted feeding on metabolic risk in postmenopausal women, who may be particularly vulnerable to disruption of circadian eating rhythms and the associated metabolic dysfunction. It is hypothesized that time-restricted feeding will improve insulin sensitivity, glucose tolerance, body weight, and other metabolic parameters in metabolically-unhealthy postmenopausal women.

Interventions

  • BEHAVIORAL Time-Restricted Feeding (TRF)

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2021-10-19
Est. Completion 2027-01-31
Phase NA

Sponsor

Julie Pendergast

3 total trials

What the Registry Record Tells You About NCT04893226

The ClinicalTrials.gov registry entry for NCT04893226 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,203-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (86% lower). The listed sponsor is Julie Pendergast, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Time-Restricted Feeding (TRF) is the first listed.

NCT04893226 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT04893226 about?

NCT04893226 is a clinical study titled "Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women". This is a randomized, parallel two-arm clinical trial design to study the efficacy of time-restricted feeding on metabolic risk in postmenopausal women, who may be particularly vulnerable to disruption of circadian eating rhythms and the associated metabolic dysfunction. It is hypothesized that time...

What is the current status of trial NCT04893226?

This trial is currently recruiting. It is a NA study. The enrollment target is 164 participants. The study started on 2021-10-19. Estimated completion is 2027-01-31.

What conditions does trial NCT04893226 study?

This clinical trial studies the following conditions: Metabolic Syndrome, Postmenopausal Symptoms.

What interventions are being tested in trial NCT04893226?

The interventions under investigation include: Time-Restricted Feeding (TRF) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04893226?

This trial is sponsored by Julie Pendergast, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04893226 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.